Successful combined auxiliary partial liver and intestinal transplantation in two highly sensitized, cross‐match positive patients
Clinical Transplantation · 2023-03 · 37 (3)
DOI: 10.1111/ctr.14865 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, online erschienen am 09.01.2023. Verfasst von Guosheng Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Intestinal Transplant Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Kidney Transplantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Introduction
Sensitization to human leukocyte antigen (HLA) creates an immunological barrier to intestinal transplantation (ITx). Current desensitization therapies are limited and ineffective in the most highly sensitized patients. A co‐transplanted whole liver transplant can protect a kidney, heart, or intestinal allograft from antibody‐mediated injury. Whether an auxiliary partial liver allograft provides effective protection for highly sensitized intestinal transplant recipients is unknown.
Methods
Two patients with strong HLA donor‐specific antibody at high titer against their deceased donors underwent combined auxiliary partial liver and ITx across a positive cross‐match. The left lateral lobes from the combined‐graft recipients and the right liver lobes from the deceased donors were transplanted as a domino procedure to other four patients.
Results
Two combined‐graft recipients have had an uneventful postoperative course without major complications at a 12‐ and 24‐month follow‐up, respectively. Intestinal graft function has been excellent with no evidence of humoral or cellular rejection. While a positive cross‐match turned negative, titers of donor‐specific HLA antibodies gradually declined over time after transplant. The left liver lobes procured from the combined‐graft recipients were successfully transplanted into two pediatric patients (age 1.9, 2.4 years) and the right lobes from two deceased donors were successfully transplanted into two adult patients. All transplant procedures went well, without post‐operative complications related to the splitting technique.
Conclusion
Our results indicate that an auxiliary liver transplant can effectively protect a co‐transplanted intestinal allograft against rejection and suggest that this combined procedure may serve as a useful therapeutic adjunct for a highly sensitized intestinal transplant candidate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Intestinal Transplant Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Zhejiang University Cancer Center, Zhejiang University, Hangzhou, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wu, G., Liu, C., Ma, N., Zhou, X., Zhao, L., Zhang, Y., Zhang, W., & Liang, T. (2023). Successful combined auxiliary partial liver and intestinal transplantation in two highly sensitized, cross‐match positive patients. Clinical Transplantation, 37(3). https://doi.org/10.1111/ctr.14865
Vancouver
Wu G, Liu C, Ma N, Zhou X, Zhao L, Zhang Y, et al. Successful combined auxiliary partial liver and intestinal transplantation in two highly sensitized, cross‐match positive patients. Clinical Transplantation. 2023;37(3). doi:10.1111/ctr.14865
BibTeX
@article{Wu2023,
author = {Wu, Guosheng and Liu, Chaoxu and Ma, Nan and Zhou, Xile and Zhao, Long and Zhang, Yuntao and Zhang, Wentong and Liang, Tingbo},
title = {Successful combined auxiliary partial liver and intestinal transplantation in two highly sensitized, cross‐match positive patients},
journal = {Clinical Transplantation},
year = {2023},
volume = {37},
number = {3},
doi = {10.1111/ctr.14865}
}
EUVIMED